FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation

Cell Rep. 2023 May 30;42(5):112530. doi: 10.1016/j.celrep.2023.112530. Epub 2023 May 18.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a chronic metabolic disorder caused by overnutrition and can lead to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). The transcription factor Forkhead box K1 (FOXK1) is implicated in regulation of lipid metabolism downstream of mechanistic target of rapamycin complex 1 (mTORC1), but its role in NAFLD-NASH pathogenesis is understudied. Here, we show that FOXK1 mediates nutrient-dependent suppression of lipid catabolism in the liver. Hepatocyte-specific deletion of Foxk1 in mice fed a NASH-inducing diet ameliorates not only hepatic steatosis but also associated inflammation, fibrosis, and tumorigenesis, resulting in improved survival. Genome-wide transcriptomic and chromatin immunoprecipitation analyses identify several lipid metabolism-related genes, including Ppara, as direct targets of FOXK1 in the liver. Our results suggest that FOXK1 plays a key role in the regulation of hepatic lipid metabolism and that its inhibition is a promising therapeutic strategy for NAFLD-NASH, as well as for HCC.

Keywords: CP: Metabolism; FOXK1; Forkhead box K1; HCC; NAFLD; NASH; conditional knockout mouse; hepatocellular carcinoma; lipid metabolism; mTORC1; mechanistic target of rapamycin complex 1; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular* / metabolism
  • Fatty Acids / metabolism
  • Lipid Metabolism
  • Liver / metabolism
  • Liver Neoplasms* / pathology
  • Mechanistic Target of Rapamycin Complex 1 / metabolism
  • Mice
  • Non-alcoholic Fatty Liver Disease* / metabolism

Substances

  • Fatty Acids
  • Mechanistic Target of Rapamycin Complex 1
  • Foxk1 protein, mouse